Using a combination of transcriptomic, proteomic, and metabolomic approaches, Valli et al. found that hypoxic HCT116 colorectal cancer cells were able to adapt to HIF-1α deletion via HIF-1-independent metabolic pathways [58]. The gene discussed is HIF1A; the disease is colorectal cancer.